Ambac Financial Group (OSG) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
Completed a multi-year strategic transformation, selling the Legacy Financial Guarantee business for $420 million and rebranding as a pure-play specialty P&C company focused on insurance distribution and specialty underwriting.
Acquired ArmadaCorp Capital for $250 million, expanding insurance distribution and product diversification.
Consolidated Pivix Specialty Insurance Services as a majority-owned MGA, increasing ownership to 74%.
Total revenue from continuing operations rose 6.5% to $251 million; Insurance Distribution premiums up 93% to $952 million, while Specialty P&C premiums declined 6% to $360 million.
Executed cost reduction initiatives, including reductions in executive and board compensation, staff levels, and headquarters relocation.
Voting matters and shareholder proposals
Election of seven directors to serve until the next annual meeting.
Advisory vote to approve executive compensation (say-on-pay).
Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026.
Approval of the 2026 Incentive Compensation Plan, replacing the 2024 plan and authorizing 1,200,000 new shares for awards.
Board of directors and corporate governance
Board consists of seven directors, six of whom are independent; separate Chairman and CEO roles.
Board committees include Audit, Compensation, Governance and Nominating, and Strategy, each with defined responsibilities and independent membership.
Annual board self-evaluation and ongoing stockholder engagement on governance and compensation.
Director compensation includes cash and equity components, with reduced equity grants post-sale of legacy business.
Mandatory director shareholding requirements and diversity focus in board composition.
Latest events from Ambac Financial Group
- Board recommends approval of all annual meeting proposals, including director elections and compensation.OSG
Proxy filing10 Apr 2026 - Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026 - Revenue up 27% and P&C premium up 70%, but net loss widened on higher expenses.OSG
Q1 20257 Jan 2026 - Record premium growth and margin gains offset by $548M net loss from legacy business sale.OSG
Q4 202423 Dec 2025 - Vote on $420M sale of AAC to Oaktree, executive pay, and adjournment; board recommends approval.OSG
Proxy Filing2 Dec 2025 - Shareholders to vote on $420M sale, board-backed, with new capital and governance terms.OSG
Proxy Filing2 Dec 2025